VIDEO | Top of page |
PRN no longer offers CME or ABIM MOC. | Top of page |
About the Presenter: | Top of page |
Learning Objectives: | Top of page |
1. Understand updated approaches to anal cancer screening, and the role of high risk HPV in people with HIV.
2. Appreciate the global role of dolutegravir, the significance of resistance testing for integrase inhibitors, and how to best way to sequence from TLD with limited monitoring.
3. Consider the impact of new data on cardiometabolic health and weight gain.
4. Be aware of current approaches and issues arising in providing holistic HIV care for trans individuals and communities.
Disclosure Statement: | Top of page |
- Dr. James F. Braun (Course Director/Planner) has no relevant financial relationships to disclose.
- Dr. William M. Valenti (Moderator) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Research grants from Gilead and ViiV. All relevant financial relationships have been mitigated.
- Dr. Tristan J. Barber, MD (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Consultant to Gilead, Janssen, Merck and ViiV. Dr. Barber submitted his slides in advance for adequate peer review and will support his presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.